399 related articles for article (PubMed ID: 17622531)
21. Antitumor activity of the novel vascular targeting agent ZD6126 in a panel of tumor models.
Blakey DC; Westwood FR; Walker M; Hughes GD; Davis PD; Ashton SE; Ryan AJ
Clin Cancer Res; 2002 Jun; 8(6):1974-83. PubMed ID: 12060643
[TBL] [Abstract][Full Text] [Related]
22. Potent antitumor activity of a novel nucleoside analogue, BCH-4556 (beta-L-dioxolane-cytidine), in human renal cell carcinoma xenograft tumor models.
Kadhim SA; Bowlin TL; Waud WR; Angers EG; Bibeau L; DeMuys JM; Bednarski K; Cimpoia A; Attardo G
Cancer Res; 1997 Nov; 57(21):4803-10. PubMed ID: 9354442
[TBL] [Abstract][Full Text] [Related]
23. Relation between Irofulven (MGI-114) systemic exposure and tumor response in human solid tumor xenografts.
Leggas M; Stewart CF; Woo MH; Fouladi M; Cheshire PJ; Peterson JK; Friedman HS; Billups C; Houghton PJ
Clin Cancer Res; 2002 Sep; 8(9):3000-7. PubMed ID: 12231547
[TBL] [Abstract][Full Text] [Related]
24. Antitumor activity of titanocene dichloride in xenografted human renal-cell carcinoma.
Köpf-Maier P
Anticancer Res; 1999; 19(1A):493-504. PubMed ID: 10226588
[TBL] [Abstract][Full Text] [Related]
25. Taurolidine: cytotoxic and mechanistic evaluation of a novel antineoplastic agent.
Calabresi P; Goulette FA; Darnowski JW
Cancer Res; 2001 Sep; 61(18):6816-21. PubMed ID: 11559556
[TBL] [Abstract][Full Text] [Related]
26. OSI-930: a novel selective inhibitor of Kit and kinase insert domain receptor tyrosine kinases with antitumor activity in mouse xenograft models.
Garton AJ; Crew AP; Franklin M; Cooke AR; Wynne GM; Castaldo L; Kahler J; Winski SL; Franks A; Brown EN; Bittner MA; Keily JF; Briner P; Hidden C; Srebernak MC; Pirrit C; O'Connor M; Chan A; Vulevic B; Henninger D; Hart K; Sennello R; Li AH; Zhang T; Richardson F; Emerson DL; Castelhano AL; Arnold LD; Gibson NW
Cancer Res; 2006 Jan; 66(2):1015-24. PubMed ID: 16424037
[TBL] [Abstract][Full Text] [Related]
27. CNS 7056: a novel ultra-short-acting Benzodiazepine.
Kilpatrick GJ; McIntyre MS; Cox RF; Stafford JA; Pacofsky GJ; Lovell GG; Wiard RP; Feldman PL; Collins H; Waszczak BL; Tilbrook GS
Anesthesiology; 2007 Jul; 107(1):60-6. PubMed ID: 17585216
[TBL] [Abstract][Full Text] [Related]
28. Quinols as novel therapeutic agents. 2.(1) 4-(1-Arylsulfonylindol-2-yl)-4-hydroxycyclohexa-2,5-dien-1-ones and related agents as potent and selective antitumor agents.
Berry JM; Bradshaw TD; Fichtner I; Ren R; Schwalbe CH; Wells G; Chew EH; Stevens MF; Westwell AD
J Med Chem; 2005 Jan; 48(2):639-44. PubMed ID: 15658878
[TBL] [Abstract][Full Text] [Related]
29. CUDC-305, a novel synthetic HSP90 inhibitor with unique pharmacologic properties for cancer therapy.
Bao R; Lai CJ; Qu H; Wang D; Yin L; Zifcak B; Atoyan R; Wang J; Samson M; Forrester J; DellaRocca S; Xu GX; Tao X; Zhai HX; Cai X; Qian C
Clin Cancer Res; 2009 Jun; 15(12):4046-57. PubMed ID: 19509149
[TBL] [Abstract][Full Text] [Related]
30. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
[TBL] [Abstract][Full Text] [Related]
31. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
[TBL] [Abstract][Full Text] [Related]
32. CHS 828, a novel pyridyl cyanoguanidine with potent antitumor activity in vitro and in vivo.
Hjarnaa PJ; Jonsson E; Latini S; Dhar S; Larsson R; Bramm E; Skov T; Binderup L
Cancer Res; 1999 Nov; 59(22):5751-7. PubMed ID: 10582695
[TBL] [Abstract][Full Text] [Related]
33. Preclinical evaluation of the novel multi-targeted agent R1530.
Kolinsky K; Tovar C; Zhang YE; Railkar A; Yang H; Carvajal D; Nevins T; Geng W; Linn M; Packman K; Liu JJ; Zhang Z; Wovkulich P; Ju G; Higgins B
Cancer Chemother Pharmacol; 2011 Dec; 68(6):1585-94. PubMed ID: 21553286
[TBL] [Abstract][Full Text] [Related]
34. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the antitumor activity of recombinant human gamma-interferon employing human melanoma xenografts in athymic nude mice.
Trotta PP; Harrison SD
Cancer Res; 1987 Oct; 47(20):5347-53. PubMed ID: 3115565
[TBL] [Abstract][Full Text] [Related]
36. Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme.
Liu C; Sarkaria JN; Petell CA; Paraskevakou G; Zollman PJ; Schroeder M; Carlson B; Decker PA; Wu W; James CD; Russell SJ; Galanis E
Clin Cancer Res; 2007 Dec; 13(23):7155-65. PubMed ID: 18056196
[TBL] [Abstract][Full Text] [Related]
37. Preclinical antitumor activity of 4'-thio-beta-D-arabinofuranosylcytosine (4'-thio-ara-C).
Waud WR; Gilbert KS; Shepherd RV; Montgomery JA; Secrist JA
Cancer Chemother Pharmacol; 2003 May; 51(5):422-6. PubMed ID: 12679884
[TBL] [Abstract][Full Text] [Related]
38. Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines.
Massi P; Vaccani A; Ceruti S; Colombo A; Abbracchio MP; Parolaro D
J Pharmacol Exp Ther; 2004 Mar; 308(3):838-45. PubMed ID: 14617682
[TBL] [Abstract][Full Text] [Related]
39. The antitumor activity of the somatostatin structural derivative (TT-232) on different human tumor xenografts.
Tejeda M; Gaal D; Barna K; Csuka O; Kéri G
Anticancer Res; 2003; 23(5A):4061-6. PubMed ID: 14666719
[TBL] [Abstract][Full Text] [Related]
40. Intraarterial administration of melphalan for treatment of intracranial human glioma xenografts in athymic rats.
Kurpad SN; Friedman HS; Archer GE; McLendon RE; Petros WM; Fuchs HE; Guaspari A; Bigner DD
Cancer Res; 1995 Sep; 55(17):3803-9. PubMed ID: 7641197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]